SEATTLE, May 31, 2011 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced
today that Robert
Kirkman, M.D., President and Chief Executive Officer,
will present at the Jefferies 2011 Global Healthcare Conference in New
York on Monday, June 6, 2011, at 8:30
A live and archived webcast of Dr. Kirkman's presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
Subscribe to our Free Newsletters!
This is a branch of telemedicine that delivers eye care via a digital medical equipment and ...
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...View All